Alopecia: introduction and overview of herbal treatment (original) (raw)

Alopecia areata: An update

Indian Journal of Dermatology, Venereology, and Leprology, 2013

Alopecia areata (AA) is a common form of non-scarring hair loss of scalp and/or body. Genetic predisposition, autoimmunity, and environmental factors play a major role in the etiopathogenesis of AA. Patchy AA is the most common form. Atopy and autoimmune thyroiditis are most common associated conditions. Peribulbar and intrabulbar lymphocytic infl ammatory infi ltrate resembling "swarm of bees" is characteristic on histopathology. Treatment is mainly focused to contain the disease activity. Corticosteroids are the preferred treatments in form of topical, intralesional, or systemic therapy. Camoufl age in the form of wigs may be an alternative option in refractory cases.

Alopecia areata (Indralupta): A case successfully treated with ayurvedic management

Journal of Ayurvedic and Herbal Medicine, 2017

Alopecia areata, an autoimmune disease characterised by hair loss can be correlated with Indralupta in Ayurveda. Due to side effects and limitation of the contemporary science, some harmless and effective medicines are expected from Alternative medical sciences. Ayurveda has great potential to treat such autoimmune diseases. Here a case of alopecia areata successfully treated with Ayurvedic management is recorded.

Alopecia Areata. Current situation and perspectives

Archivos Argentinos De Pediatria, 2017

Alopecia areata (AA) is a dermatological disease characterized by non-scarring hair loss of the scalp and/or body, with an unpredictable and variable evolution in the patients in which, despite multidisciplinary efforts, its etiology is not entirely known, although some evidence suggests that environmental, immunological and genetic factors could be generating the disease. The aim of this review is to provide an updated panorama of the clinical characteristics, diagnosis and treatment of AA, to analyze the mechanisms that could participate in its etiology, as well as to review some of the most important genetic variants that could confer susceptibility to the development of this disease.

Management of alopecia areata: an update

2012

Alopecia areata is a common, non-scarring, autoimmune disorder affecting any hair-bearing area. It is often psychologically devastating. This disorder occurs in both the sexes, in all age groups, and is characterized by the sudden appearance of circumscribed areas of hair loss on the scalp or other parts of the body. Various therapeutic approaches are presently available for managing alopecia areata including corticosteroids, contact sensitizers and immunosuppressants, but none have been shown to alter the course of the disease on a consistent basis.

Alopecia Areata – A literature Review

Alopecia areata (AA) is a disease marked by extreme variability in hair loss, not only at the time of initial onset of hair loss but in the duration, extent and pattern of hair loss during any given episode. This variable and unpredictable nature of spontaneous re-growth and lack of a uniform response to various therapies has made clinical trials in alopecia areata difficult to plan and implement. It is a type of alopecia that affects males and females equally. It occurs in both children and adults. The peak age of occurrence is 20 to 50 years .The most common clinical presentation is asymptomatic shedding of telogen hairs followed by patchy non scarring hair loss in association with nail pitting, Beau's line and nail dystrophy. The disease may progress from this limited presentation to total loss of all scalp hairs (Alopecia totalis) or all body hair (alopecia universalis) with significant onychodystrophy. Mostly it is characterised by reversible hair loss involving the scalp although others areas of head including eyelashes, eyebrows and beard may also be affected. Although, it is a mostly cosmetic problem but it often has devastating effects on quality of life and self-esteem. The paper aims at providing an overview of Alopecia areata.

Alopecia Areata: A Case Report

Medical Clinical Update, 2023

Background The frequent asymptomatic condition alopecia areata (AA) is characterized by the sudden start of total hair loss in a sharply defined, typically spherical area. Complicated autoimmune diseases both hereditary and environmental factors affected the susceptibility to and severity of the disease. About 34-50% of patients experience a spontaneous recovery within a year, while patients may go through many alopecia bouts. The purpose of this case report is to go over the identification and management of alopecia areata. Case presentation The main complaint of a 27-year-old male patient, a construction worker, was asymptomatic loss of hair over the scalp at several spots for a month. The patient acknowledged that a head injury to the right parietal area, accompanied by a depressive-type lesion without hair loss, had occurred prior to this. After three weeks of trauma, the hair loss began as a little patch that ranged in size from 2 cm by 2 cm and progressively grew larger and more numerous each day. This patient has never received treatment before because of his illness. A dermatological examination revealed diffuse hair loss across the entire scalp without any areas of patchy hair loss, and the majority of his hair was easily pulled out with just a moderate tug. Conclusion Alopecia areata can be treated with proper treatment, however, patients with alopecia areata may have recurrent episodes of hair loss. Therefore, preventive measures are needed to reduce the recurrence of this condition. Physicians should be able to treat alopecia adequately. Adequate treatment may reduce the recurrence of alopecia areata and will increase the patient's quality of life.

Advances in the management of alopecia areata

The Journal of dermatology, 2012

Spontaneous remission occurs in up to 80% of patients with limited patchy alopecia areata (AA) within 1 year. Therefore, not all patients of AA simplex/multiplex need extensive treatments, and "wait and see" is one of the choices for some patients. However, once the hair loss show progressive course, it is really difficult to manage well and may be recalcitrant to any treatment in some cases. Hair loss symptom is not life-threatening but severely decreases quality of life. There have been two widely known guidelines for AA from the British Association of Dermatologists and the National Alopecia Areata Foundation (USA). These guidelines have been substantial and provide clues for dermatologists but needed to be updated. Recently, the Japanese Dermatological Association also published a guideline for the management of AA. This guideline suggests treatments followed by recommendations and evidence levels. Several new treatments are added such as corticosteroid pulse therapy a...

Prevalence and treatment of Alopecia areata in Taif area, KSA

Saudi Journal for Health Sciences, 2015

Background: Alopecia areata (AA) is one type of hair loss that typically causes patches of baldness. In some cases, total baldness develops. There are no adequate studies concerning AA on the Taif area residents, KSA. Aim: The present study conducted for the first time prevalence, causes and treatment of AA in Al-Taif area, KSA. Materials and Methods: A questionnaire employed to determine the prevalence of AA in patients attending dermatology clinics in Al-Taif area. The doctors questioned about the number of patients attend dermatology clinics and suffering from AA. Doctors also were asked about types, causes of AA and the treatment/ responsiveness. The data collected and analysed statistically. Results: The obtained results showed a noticeable prevalence of AA in Al-Taif area; 6.750% in males and 6.375% in females. Localized AA was the most common (88.75%) as well as the most responsive to the treatment. The emergence of disease was mostly related to the immune system (85%). The Doctors preferred topical corticosteroids or minoxidil plus systemic vitamins and minerals treatment more than others due to its effectiveness (90%, 40% responsiveness in localized and diffused respectively). Conclusion: We concluded that, the incidence of AA disease in Al-Taif area, exceeded expectations and the autoimmune condition is the most predominance reason for its occurrence. The most effective treatment was topical corticosteroids plus systemic vitamins and minerals. Recommendations: We recommend a vitamin-rich diet as well as an increased emphasis on the use of topical rubefacient herbs in addition to the above mentioned treatments of AA.